La structure de la chromatine régule le traitement du pré-ARNm

Nucleosomes act as physical barriers that temporarily pause RNA polymerase activity on DNA. Strategically positioned nucleosomes, such as those after the promoter element, force RNA polymerase to pause at the transcriptional start site. This pause allows time for assembly of elongation factors and chromatin remodeling complexes that create nucleosome-free regions, enabling proper transcription initiation and processing of the nascent pre-mRNA.

Specific histone modifications on exon-rich nucleosomes recruit spliceosome components directly to the emerging RNA. Histone acetylation creates open chromatin allowing faster RNA polymerase activity, recruiting splicing factors only to strong splice sites and excluding alternative exons. Conversely, histone deacetylation tightens chromatin structure, slowing polymerase activity and enabling recruitment of splicing factors to weak splice sites, promoting alternative exon inclusion.

Transcription and pre-mRNA processing occur simultaneously in eukaryotes rather than sequentially. As RNA polymerase synthesizes pre-mRNA, processing factors immediately bind the nascent transcript. This coupling allows chromatin structure to directly regulate both transcription rate and processing steps, ensuring efficient and coordinated mRNA maturation before the transcript exits the nucleus.

Trimethylation of histone H3 lysine 36 on nucleosomes enriches exonic regions and recruits splicing factors to correct splice sites. This histone modification helps ensure accurate exon-intron boundaries during splicing. Mutations disrupting this methylation process can cause intron retention in mature mRNA, leading to mRNA degradation or production of defective proteins associated with neurodegenerative disorders and cancer.

Replacement of normal histone H3 with variant histones on the gene body impairs recruitment of splicing factors, leading to defective splicing. This causes intron retention in the mature mRNA, which triggers degradation through the nonsense-mediated decay pathway or introduces mutations in translated proteins. Such abnormal splicing events are implicated in neurodegenerative diseases and cancer development.

Chromatin structure regulates both constitutive and alternative splicing through nucleosome positioning and histone modifications, generating diverse mRNA transcripts from single genes. Different histone modification patterns at exon-specific nucleosomes determine which exons are included or excluded during splicing. This regulatory mechanism produces an enormous pool of distinct mRNA variants and corresponding proteins from a finite set of genes.

RNA polymerase transcription rate, controlled by chromatin structure, directly determines when spliceosome components can be recruited to splice sites. Slower polymerase activity provides more time for splicing factor assembly at weak splice sites, while faster activity limits recruitment to strong sites only. This kinetic coupling between transcription speed and splicing efficiency allows chromatin modifications to fine-tune which exons are included in the mature mRNA.